SAYPHA FILLERS

CROMA - PRINCESS - SAYPHA CROMA HA FILLER

EN 2019 CROMA PRINCESS BECOMES CROMA SAYPHA

The  CROMA SAYPHA range of dermal fillers is produced by the Austrian company Croma-Pharma GmbH, a company with a long history of creating hyaluronic acid (HA).
CE Marked Medical Device. SMART - a unique method of cross–linking created by CROMA.
They ensure that their products are of the highest quality, with carefully selected components and a unique, automated manufacturing process. 

ADVANTAGES SAYPHA CROMA INJECTABLE

• Re-establishing your natural HA level, Croma Injectables will reverse the signs of aging, making you look younger, fresher and more radiant.
• Resulting in a minimal recovery time and a natural, immediately visible effect.
• Optimal skin-tolerance. Usage of hyaluronic acid of non-animal origin.
• Treatment satisfaction.
• Nearly 98% patients are satisfied with our products.
• Immediately visible.
• Instant results with a natural effect.
• Painless treatment.
• Due to the addition of lidocaine to our products and the usage of very fine needles.
• Natural effect and exceptional product performance.
• Results last for several months.

ABOUT SAYPHA BY CROMA Croma's range of hyaluronic acid fillers includes 6 products:

• SAYPHA® RICH (EC 0459)
• SAYPHA® FILLER (CE 0459) and
• SAYPHA® FILLER Lidocaine (CE 0120)
• SAYPHA® VOLUME (CE 0459) and
• SAYPHA® VOLUME Lidocaine (EC 0120)
• SAYPHA® VOLUME PLUS Lidocaine (EC 0120)

DESCRIPTION GAMME SAYPHA 6 PRODUCTS

SAYPHA FILLER +/- LIDOCAIN

• UNIVERSAL
• Cross linked HA 2.3% (23 mg/ml)+/- LIDOCAIN (0,3 mg/ml)
• Level of cross-linking 2/4
• BDDE (9%)
• Needle 27G1/2
• Up to 9 months.
• Is a sterile, biodegradable, viscoelastic, perfectly clear, colourless, isotonic, homogenized and monophasic gel implant. To correct moderate to severe wrinkles and facial wrinkles and increases lip volume (only applicable for SAYPHA® FILLER Lidocaine)
• SAYPHA FILLER is indicated for the correction of moderate to severe wrinkles.
• Indicated for perioral wrinkles, lip contour and lip volume increase. It can be used for all areas of the face except the eye contour.
• Recommended to inject SAYPHA® FILLER into the mid to deep dermis to achieve a very natural look and long-lasting correction.

SAYPHA VOLUME +/- LIDOCAIN

• VOLUMISING.
• Cross linked HA 2.3% (23 mg/ml)+/- LIDOCAIN (0,3 mg/ml)
• Level of cross-linking 3/4
• BDDE (14%)
• Needle 27G1/2
• Up to 9 months.
• SAYPHA VOLUME is a monophasic, sterile, biodegradable, viscoelastic, clear, isotonic, highly cross-linked and homogenized gel implant.
• Indicated for the correction of deep wrinkles and folds, cutaneous depressions, facial contours and the creation of volume.
• Developed to correct deeper wrinkles and wrinkles and to restore facial volume / reshape facial contours. The product is injected into the deeper skin layer (deep dermis or hypodermis).
• Injected using a 27G needle for a less traumatic injection thanks to its optimal visco-elasticity and a well adapted size of syringe.

SAYPHA RICH

• HYDRATATION
• Non-cross linked HA 1.8% (18 mg/ml) +glycerol.
• Level of cross-linking 0/4
• Needle 30G1/2
• SAYPHA RICH is a sterile, viscoelastic, clear, colourless, transparent, isotonic and biodegradable gel. Non-cross linked and stabilised with glycerol. Based on the SMART technique, the gel is not cross-linked but stabilized by glycerol, a natural moisturizer, which retains water and preserves hydration.
• Regenerates the loss of hyaluronic acid due to aging, improves hydration, skin tone and elasticity and corrects fine lines. 
• High concentration of HA and a very high molecular weight (3.0 mio Daltons) for long-lasting rejuvenation effects.
• The combination of HA and glycerol durably increases the hydration of the skin. Indicated for mesotherapy treatments. Injected into the superficial dermis it improves the tone and elasticity of the skin, gives a glow to the complexion and holds off the signs of skin ageing. For better results, it is recommended to have 3 treatments at a three weeks interval.

SAYPHA VOLUME PLUS LIDOCAINE

• RESHAPING-RESTORING
• Cross linked HA 2.5% (25 mg/ml)+ LIDOCAIN (0,3 mg/ml)
• Level of cross-linking 4/4
• Needle 27G1/2
• Up to 12 months
• BDDE.
• SAYPHA VOLUME PLUS LIDOCAINE is a monophasic, highly-cross linked gel implant, based on hyaluronic acid of non-animal origin.
• Used for facial tissue augmentation to correct lowering of the volume of the middle part of the face and to define the contours of the face as well as for reconstruction purposes, for example in the treatment of facial lipoatrophy.
• Injected subcutaneously, locally or in the deep dermis. Hyaluronic acid is the key ingredient in Volume Plus to eradicate wrinkles by increasing the volume within the skin tissue.
• Indicated for the correction of deep wrinkles and folds, cutaneous depressions, facial contours and the creation of volume. Very high elasticity and ability to increase the skin volume.
• For severe facial wrinkles, loss of volume and improvement of facial contours. Deep and volumetric treatments. Skin regains its vitality, firmness and glowing youthful energy.

ABOUT CROMA-PHARMA GmbH

Founded in 1976, Croma-Pharma GmbH (Croma) is an Austrian family-owned company specializing in the industrial production of hyaluronic acid for the fields of aesthetic medicine, ophthalmology and orthopedics. Croma currently manages 12 international sales companies and distributes its products in more than 70 countries. In its global sales network, Croma focuses on its own brand products for minimally invasive cosmetic medicine.